ADT combined with abiraterone

DRUG2 trials

Sponsors

Changhai Hospital

Conditions

Oligo-metastatic Prostate CarcinomaOligometastatic Prostate Carcinoma

Unknown Phase

Neoadjuvant Radiohormonal Therapy for Oligometastatic Prostate Cancer

Not yet recruitingNCT05707468

Changhai HospitalOligometastatic Prostate Carcinoma

Start: 2024-05-01End: 2028-03-01Target: 200Updated: 2024-02-20

Radiotherapy for Prostate and Oligo-metastatic Lesions in Patients With Low-burden Oligo-metastatic Prostate Cancer

Not yet recruitingNCT06198387

Changhai HospitalOligo-metastatic Prostate Carcinoma

Start: 2024-01-01End: 2028-09-01Target: 30Updated: 2024-01-10

Related Papers

NEoAdjuvant radiohormonal therapy versus standard of care for oligometastatic prostate cancer (NEAR-TOP): study protocol of a multicenter, open-label, randomised controlled trial.

2025-04-24

Protocol for Evaluating the Efficacy and Safety of Radiotherapy for Prostate and Oligometastatic Lesions in Patients With Low-Burden Sensitive Oligometastatic Prostate Cancer: An Open, Exploratory Pilot Clinical Trial

Cancer Control2024-01-011 citations